Guggenheim Capital LLC Neogenomics Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $150,322 - $246,903	-19,125 Reduced 18.54%	84,007 $723,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $194,432 - $384,733	27,540 Added 36.43%	103,132 $841,000
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $245,235 - $712,091	20,184 Added 36.43%	75,592 $919,000
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $1.53 Million - $2.43 Million	50,159 Added 955.59%	55,408 $1.89 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $118,314 - $149,156	-2,840 Reduced 35.11%	5,249 $253,000
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $64,817 - $91,491	-1,770 Reduced 17.95%	8,089 $365,000
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $1.41 Million - $2.04 Million	-34,035 Reduced 77.54%	9,859 $475,000
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $140,134 - $219,329	3,884 Added 9.71%	43,894 $2.36 Million
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $109,724 - $133,543	-3,299 Reduced 7.62%	40,010 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $90,763 - $116,293	3,749 Added 9.48%	43,309 $1.34 Million
Q1 2020 Jun 02, 2020	SELL	$20.5 - $34.53 $118,715 - $199,963	-5,791 Reduced 12.77%	39,560 $1.09 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $138,844 - $218,518	-7,323 Reduced 13.9%	45,351 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $618,245 - $848,470	-32,335 Reduced 38.04%	52,674 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $79,669 - $98,111	4,071 Added 5.03%	85,009 $1.87 Million
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $537,595 - $906,030	44,283 Added 120.81%	80,938 $1.66 Million
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $19,849 - $32,671	-1,766 Reduced 4.6%	36,655 $462,000
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $14,900 - $18,332	-1,192 Reduced 3.01%	38,421 $590,000
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $11,090 - $19,501	-1,388 Reduced 3.39%	39,613 $518,000
Q1 2018 May 15, 2018	BUY	$7.23 - $8.76 $11,163 - $13,525	1,544 Added 3.91%	41,001 $334,000
Q4 2017 Feb 14, 2018	BUY	$8.02 - $11.18 $100,554 - $140,174	12,538 Added 46.58%	39,457 $351,000
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $245,232 - $303,107	26,919	26,919 $299,000

Others Institutions Holding NEO

# of Institutions

293

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$281 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$201 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$98.5 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$94.4 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$93.5 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account